Achilles Therapeutics PLC (ACHL)
1.06
-0.01
(-0.93%)
USD |
NASDAQ |
Nov 22, 14:02
Achilles Therapeutics Total Assets (Quarterly): 122.68M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 122.68M |
| June 30, 2024 | 131.19M |
| March 31, 2024 | 145.74M |
| December 31, 2023 | 161.46M |
| September 30, 2023 | 175.34M |
| June 30, 2023 | 197.91M |
| March 31, 2023 | 207.64M |
| December 31, 2022 | 220.36M |
| Date | Value |
|---|---|
| September 30, 2022 | 227.35M |
| June 30, 2022 | 257.72M |
| March 31, 2022 | 292.19M |
| December 31, 2021 | 317.11M |
| September 30, 2021 | 330.00M |
| June 30, 2021 | 353.49M |
| March 31, 2021 | 206.10M |
| December 31, 2020 | 218.92M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
122.68M
Minimum
Sep 2024
353.49M
Maximum
Jun 2021
222.82M
Average
213.28M
Median
Total Assets (Quarterly) Benchmarks
| Autolus Therapeutics PLC | 827.49M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| Centessa Pharmaceuticals PLC | 609.72M |
| Adaptimmune Therapeutics PLC | 317.44M |
| Verona Pharma PLC | 381.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.54M |
| Shareholders Equity (Quarterly) | 103.14M |